Generation Bio Co.
NASDAQ:GBIO
Overview | Financials
Company Name | Generation Bio Co. |
Symbol | GBIO |
Currency | USD |
Price | 2.16 |
Market Cap | 144,160,992 |
Dividend Yield | 0% |
52-week-range | 1.02 - 4.65 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Cameron Geoffrey McDonough M.D. |
Website | https://generationbio.com |
An error occurred while fetching data.
About Generation Bio Co.
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD